Parvovirus B19-antibody serosurvey in 500 developmentally disabled subjects.

Abstract

Sera of 500 residents were screened for parvovirus B19 immunoglobulin M (IgM) and immunoglobulin G (IgG) by enzyme-linked immunosorbent assay. Positive IgM and equivocal IgG or IgM results were confirmed by immunofluorescent antibody and Western blot. IgM was detected in 13 sera (2.6%), and IgG was detected in 285 (57%). Records of IgM-positive residents contained no evidence of erythema infectiosum or polyarthropathy.

• Authors: G S Lohiya, W Hogrefe, L Tan-Figueroa, S Caires
• Journal: Infection control and hospital epidemiology (Infect Control Hosp Epidemiol) Vol. 18 Issue 5 Pg. 340-2 (May 1997) ISSN: 0899-823X [Print] United States
• PMID: 9154477 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies, Viral
• Immunoglobulin G
• Immunoglobulin M

Topics

• Adult
• Antibodies, Viral (blood)
• California (epidemiology)
• Child
• Cross-Sectional Studies
• Developmental Disabilities (complications)
• Disease Reservoirs
• Health Surveys
• Humans
• Immunoglobulin G (blood)
• Immunoglobulin M (blood)
• Male
• Middle Aged
• Parvoviridae Infections (epidemiology, immunology, transmission)
• Parvovirus B19, Human (immunology, isolation & purification)
• Prospective Studies
• Residential Facilities
• Retrospective Studies
• Seroepidemiologic Studies
• Time Factors